BPG BIO

Serial Number 97861879
731

Registration Progress

Application Filed
Mar 28, 2023
Under Examination
Apr 9, 2024
Approved for Publication
Feb 13, 2024
Published for Opposition
Feb 13, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Oct 09, 2025 93 days

Basic Information

Serial Number
97861879
Deadline
October 9, 2025
Description
Statement of Use or 3rd Extension Due
Filing Date
March 28, 2023
Published for Opposition
February 13, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
Apr 9, 2025
Application
Pending
Classes
005 009 042 044

Rights Holder

BPGbio Inc.

03
Address
500 Old Connecticut Path
Framingham, MA 01701

Ownership History

BPGbio Inc.

Original Applicant
03
Framingham, MA

BPGbio Inc.

Owner at Publication
03
Framingham, MA

Legal Representation

Attorney
Lori J. Shyavitz, Esq.

USPTO Deadlines

Next Deadline
93 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
October 09, 2025
Extension Available
Until April 09, 2025

Application History

24 events
Date Code Type Description
Apr 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2025 EX2G S SOU EXTENSION 2 GRANTED
Apr 9, 2025 EXT2 S SOU EXTENSION 2 FILED
Apr 9, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2024 EX1G S SOU EXTENSION 1 GRANTED
Nov 20, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 8, 2024 EXT1 S SOU EXTENSION 1 FILED
Apr 9, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jan 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 9, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2023 GNRT F NON-FINAL ACTION E-MAILED
Sep 26, 2023 CNRT R NON-FINAL ACTION WRITTEN
Sep 12, 2023 DOCK D ASSIGNED TO EXAMINER
Apr 21, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprised of medical reagents for medical and clinical use in disease testing, bodily fluid testing, biometric testing, cardiovascular testing, heart rate testing, organ function testing, hydration testing, and nutrition testing
Class 009
Downloadable computer software for compiling and analyzing scientific and medical data; Recorded computer software for compiling and analyzing scientific and medical data; Downloadable computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Recorded computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Downloadable computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Recorded computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications
Class 042
Pharmaceutical, scientific, medical, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical and scientific research information in the field of medicine and pharmaceuticals; Medical research services in the field of cancer; Medical testing for scientific research purposes in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Data mining; Research and development in the field of biomarkers; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Providing scientific information in the field of pharmaceuticals; Pharmaceutical and medical research in the field of outcomes research; Medical research featuring the identification and validation of disease related biomarkers for use in improved patient outcomes; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical data; Software as a service (SAAS) services featuring software for big data analytics, and for collecting and analyzing data in the field of healthcare; Providing on-line, non-downloadable computer software for use in accessing and importing scientific and medical data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Platform as a service (PAAS) featuring computer software platforms for data collection, data analytics, data storage and data mining, for use in the field of healthcare
Class 044
Providing medical information in the field of medicine and pharmaceuticals; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic, prognostic and theranostic screening and testing; Theranostic assessment of a disease or condition for medical purposes; Theranostic analysis services for medical purposes; Medical diagnostic and theranostic monitoring and reporting services; Health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; Predictive modeling of data in the fields of medicine and healthcare, for medical diagnostic, prognostic and treatment purposes; Providing health information; Medical information; Providing health information, medical information, disease management information, and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, said information provided to others

Additional Information

Design Mark
The mark consists of the letters "BPG" in uppercase stylized font, a square above the top left corner of the letter "B" in "BPG", and the word "BIO" in lowercase stylized font in superscript after the letter "G".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 009 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"